Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, good morning, and thank you for standing by. Welcome to the Predictive Oncology Q1 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be an opportunity to ask your questions. Please be advised that today's conference is being recorded. And I would now like to hand the conference over to your speaker, Mr. Glenn Garman, Investor Relations. Mr. Garman, please go ahead. Welcome and thank you everyone for dialing into the Predictive Oncology first quarter 2024 financial results call. First, you'll hear from our chief executive officer and chairman of the board, Raymond Venari. Then our chief financial officer, Josh Blatcher, will review our financials. Certain matters discussed on this call contain forward-looking statements. These forward looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties, and assumptions about our operations and the investments we make. All statements other than statements of historical facts included in the call regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans, and objectives of management are forward looking statements. The words anticipate, believe, estimate, expect, intend, may, plan, would, target, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may differ materially from that contemplated by the forward-looking statements as a result of a variety of factors, including, among other things, Factors discussed under the heading Risk...